Dr. Reddy’s launches generic vitamin K1The vitamin K1 (phytonadione) injectable emulsion 10 mg/ml had a brand and generic market value of roughly $46.6 million for the 12 months ended April 2019. Rising Pharmaceuticals debuts generic CanasaMesalamine suppositories had a market value of roughly $263 million for the 12 months ended March 2019, according to IQVIA. Fresenius Kabi launches generic Precedex Fresenius Kabi is offering dexmedetomidine hydrochloride in a ready-to-use formulation. FDA gives Glenmark's generic Evoclin tentative approval Evoclin foam, 1%, had a market value of roughly $17 million for the year ended April 2019, according to IQVIA. Teva launches generic Tracleer Teva's generic Tracleer tablets offer a treatment for pulmonary arterial hypertension. Camber honored by McKesson for generics leadership Camber has received the ClarusONE Services Collaborative Supplier of the Year Award from McKesson. Zydus’ Nesher Pharmaceuticals gets FDA nod for generic Lovaza Nesher Pharmaceuticals will manufacture generic Lovaza in St. Louis, Mo. Lannett launches generic Aggrenox Aspirin and extended-release dipyridamole capsules had a market value of roughly $158 million for the 12 months ended April 2019, according to IQVIA, although actual generic market values are expected to be lower. ANI acquires Coeptis' pipeline of development stage generics ANI Pharmaceuticals has acquired Coeptis Pharmaceutical's pipeline of seven development stage generic products. Armas, Micro Labs USA partner to launch generic injectables Armas and Micro Labs USA have launched diphenhydramine injection 50mg/1mL. First Previous 185 186 187 188 189 Next Last
